Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) General Information
Description
Preclinical research stage assets including intellectual property and prodrug technologies located in Umea, Sweden.
Contact Information
Corporate Office
- Umea
- Sweden
Corporate Office
- Umea
- Sweden
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) FAQs
-
Where is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) headquartered?
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) is headquartered in Umea, Sweden.
-
What industry is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) in?
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)’s primary industry is Buildings and Property.
-
Is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) a private or public company?
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) is a Private company.
-
What is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)’s current revenue?
The current revenue for Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) is .
-
Who are Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)’s investors?
Novadex Pharmaceuticals has invested in Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden).
-
When was Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) acquired?
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) was acquired on 05-Sep-2012.
-
Who acquired Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)?
Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) was acquired by Medivir.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process